TABLE 1.
Baseline demographic and clinical characteristics of patients before and after propensity score weighting.
| Unweighted | ks.pval | Propensity score weighted | ks.pval | |||||
|---|---|---|---|---|---|---|---|---|
| Variable | Adjunctive TCM users | TCM nonusers | ks | Adjunctive TCM users | TCM nonusers | ks | ||
| (N = 462) | (N = 1,605) | (N = 462) | (N = 1,605) | |||||
| Age, mean (SD) | 57.51 ± 10.95 | 56.23 ± 11.19 | 0.05 | 0.15 | 56.62 ± 11.07 | 56.35 ± 11.1 | 0.03 | 0.81 |
| Sex, 100% | ||||||||
| Male | 365 (79) | 1316 (82) | 0.02 | 0.28 | 370 (80) | 1300 (81) | 0.01 | 0.56 |
| Female | 97 (21) | 289 (18) | 0.02 | 0.28 | 92 (20) | 305 (19) | 0.01 | 0.56 |
| Career, % | ||||||||
| Worker | 11 (2) | 32 (2) | 0 | 0.74 | 11 (2) | 32 (2) | 0 | 0.86 |
| Farmer | 213 (46) | 867 (54) | 0.07 | 0 | 236 (51) | 851 (53) | 0.02 | 0.5 |
| Leader | 5 (1) | 16 (1) | 0 | 0.43 | 5 (1) | 16 (1) | 0 | 0.86 |
| Teacher | 5 (1) | 16 (1) | 0 | 0.47 | 5 (1) | 16 (1) | 0 | 0.69 |
| Company employee | 32 (7) | 96 (6) | 0.01 | 0.55 | 23 (5) | 96 (6) | 0.01 | 0.5 |
| Other | 134 (29) | 417 (26) | 0.03 | 0.23 | 134 (29) | 433 (27) | 0.02 | 0.38 |
| Retiree | 55 (12) | 144 (9) | 0.03 | 0.08 | 42 (9) | 144 (9) | 0 | 0.91 |
| Medical insurance, % | ||||||||
| Provincial medical insurance | 55 (12) | 127 (8) | 0.04 | 0.01 | 42 (9) | 127 (8) | 0.01 | 0.56 |
| City medical insurance | 46 (10) | 127 (8) | 0.02 | 0.19 | 37 (8) | 127 (8) | 0 | 0.89 |
| NCMSa | 259 (56) | 963 (60) | 0.04 | 0.17 | 273 (59) | 963 (60) | 0 | 1 |
| None | 92 (20) | 337 (21) | 0.02 | 0.38 | 92 (20) | 337 (21) | 0.01 | 0.58 |
| Drinking history, % | 148 (32) | 562 (35) | 0.03 | 0.27 | 166 (36) | 562 (35) | 0.01 | 0.8 |
| Family history, % | ||||||||
| Liver cancer | 55 (12) | 144 (9) | 0.03 | 0.05 | 51 (11) | 144 (9) | 0.02 | 0.41 |
| Viral hepatitis | 92 (20) | 225 (14) | 0.06 | 0.01 | 74 (16) | 241 (15) | 0.02 | 0.46 |
| Medical history, % | ||||||||
| Hepatitis B | 347 (75) | 1220 (76) | 0.01 | 0.58 | 347 (75) | 1236 (77) | 0.02 | 0.44 |
| Hepatitis C | 42 (9) | 80 (5) | 0.03 | 0 | 28 (6) | 80 (5) | 0.01 | 0.58 |
| Liver cirrhosis | 273 (59) | 562 (35) | 0.25 | 0 | 208 (45) | 610 (38) | 0.07 | 0.02 |
| Alcoholic hepatitis | 9 (2) | 16 (1) | 0.01 | 0.01 | 5 (1) | 16 (1) | 0.01 | 0.2 |
| Complications, % | ||||||||
| Hepatic encephalopathy | 28 (6) | 48 (3) | 0.04 | 0 | 18 (4) | 48 (3) | 0.01 | 0.26 |
| Pulmonary infection | 42 (9) | 64 (4) | 0.04 | 0 | 32 (7) | 80 (5) | 0.02 | 0.15 |
| Upper gastrointestinal bleeding | 18 (4) | 64 (4) | 0.01 | 0.58 | 14 (3) | 64 (4) | 0 | 0.61 |
| Disease classification, % | ||||||||
| Child-Pugh stage | ||||||||
| A | 259 (56) | 819 (51) | 0.05 | 0.09 | 259 (56) | 835 (52) | 0.05 | 0.1 |
| B | 106 (23) | 385 (24) | 0.01 | 0.64 | 97 (21) | 401 (25) | 0.03 | 0.19 |
| C | 65 (14) | 273 (17) | 0.04 | 0.08 | 60 (13) | 273 (17) | 0.03 | 0.15 |
| BCLC stage | ||||||||
| 0 | 9 (2) | 32 (2) | 0.01 | 0.32 | 14 (3) | 32 (2) | 0.01 | 0.23 |
| A | 102 (22) | 385 (24) | 0.01 | 0.53 | 106 (23) | 385 (24) | 0 | 0.83 |
| B | 134 (29) | 353 (22) | 0.07 | 0 | 120 (26) | 353 (22) | 0.03 | 0.16 |
| C | 116 (25) | 514 (32) | 0.06 | 0 | 129 (28) | 498 (31) | 0.03 | 0.26 |
| D | 65 (14) | 241 (15) | 0.01 | 0.65 | 65 (14) | 225 (14) | 0.01 | 0.66 |
| Liver cancer stage | ||||||||
| Ⅰ | 116 (25) | 433 (27) | 0.02 | 0.46 | 125 (27) | 433 (27) | 0 | 0.85 |
| Ⅱ | 125 (27) | 305 (19) | 0.08 | 0 | 102 (22) | 321 (20) | 0.02 | 0.41 |
| Ⅲ | 116 (25) | 465 (29) | 0.04 | 0.11 | 134 (29) | 449 (28) | 0 | 0.86 |
| Ⅳ | 65 (14) | 289 (18) | 0.04 | 0.02 | 60 (13) | 289 (18) | 0.04 | 0.06 |